WallStSmart

Haoxi Health Technology Limited Class A Ordinary Shares (HAO)vsOmnicom Group Inc (OMC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Omnicom Group Inc generates 52551% more annual revenue ($17.27B vs $32.80M). HAO leads profitability with a 11.8% profit margin vs -0.3%. OMC earns a higher WallStSmart Score of 49/100 (D+).

HAO

Hold

42

out of 100

Grade: D

Growth: 4.0Profit: 5.0Value: 8.3Quality: 5.0

OMC

Hold

49

out of 100

Grade: D+

Growth: 5.3Profit: 4.5Value: 4.0Quality: 3.5
Piotroski: 1/9Altman Z: 0.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HAOUndervalued (+98.0%)

Margin of Safety

+98.0%

Fair Value

$61.78

Current Price

$1.26

$60.52 discount

UndervaluedFair: $61.78Overvalued

Intrinsic value data unavailable for OMC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO3 strengths · Avg: 9.7/10
P/E RatioValuation
0.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Return on EquityProfitability
27.1%9/10

Every $100 of equity generates 27 in profit

OMC3 strengths · Avg: 8.0/10
Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
27.9%8/10

Revenue surging 27.9% year-over-year

Free Cash FlowQuality
$3.00B8/10

Generating 3.0B in free cash flow

Areas to Watch

HAO4 concerns · Avg: 2.8/10
EPS GrowthGrowth
1.7%4/10

1.7% earnings growth

Market CapQuality
$69.25M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-64.6%2/10

Revenue declined 64.6%

Free Cash FlowQuality
$-3.36M2/10

Negative free cash flow — burning cash

OMC4 concerns · Avg: 2.5/10
Return on EquityProfitability
0.5%3/10

ROE of 0.5% — below average capital efficiency

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
15.972/10

Expensive relative to growth rate

EPS GrowthGrowth
-10.3%2/10

Earnings declined 10.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on P/E Ratio, Price/Book, Return on Equity.

Bull Case : OMC

The strongest argument for OMC centers on Price/Book, Revenue Growth, Free Cash Flow. Revenue growth of 27.9% demonstrates continued momentum.

Bear Case : HAO

The primary concerns for HAO are EPS Growth, Market Cap, Revenue Growth.

Bear Case : OMC

The primary concerns for OMC are Return on Equity, Piotroski F-Score, PEG Ratio.

Key Dynamics to Monitor

HAO profiles as a declining stock while OMC is a growth play — different risk/reward profiles.

OMC carries more volatility with a beta of 0.71 — expect wider price swings.

OMC is growing revenue faster at 27.9% — sustainability is the question.

OMC generates stronger free cash flow (3.0B), providing more financial flexibility.

Bottom Line

OMC scores higher overall (49/100 vs 42/100) and 27.9% revenue growth. HAO offers better value entry with a 98.0% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited Class A Ordinary Shares

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, committed to revolutionizing healthcare delivery through innovative solutions. Utilizing advanced technologies like artificial intelligence and data analytics, the company aims to enhance diagnosis, treatment efficiency, and patient management, setting new standards in healthcare practices. With a robust focus on research and development, Haoxi is well-positioned to capitalize on emerging trends in the healthcare technology landscape, presenting a significant growth opportunity for institutional investors.

Omnicom Group Inc

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Omnicom Group Inc. is an American global media, marketing and corporate communications holding company, headquartered in New York City.

Visit Website →

Want to dig deeper into these stocks?